RRC ID 58735
著者 Ogawa K, Yagi T, Guo T, Takeda K, Ohguchi H, Koyama H, Aotani D, Imaeda K, Kataoka H, Tanaka T.
タイトル Pemafibrate, a selective PPARα modulator, and fenofibrate suppress microglial activation through distinct PPARα and SIRT1-dependent pathways.
ジャーナル Biochem Biophys Res Commun
Abstract Pemafibrate, a selective peroxisome proliferator-activated receptor (PPAR) α modulator, is a new drug that specifically modulates PPARα conformation and co-activator recruitment, thereby lowers plasma triglycerides with less off-target effects. Classical PPARα ligands such as fenofibrate suppress inflammatory cells including microglia. However, effects of pemafibrate on microglia have never been addressed. Here we show that pemafibrate, like other PPARα ligands, potently suppressed NF-κB phosphorylation and cytokine expression in microglial cells. PPARα knockdown significantly amplified LPS-induced cytokine expression. Pemafibrate-induced suppression of IL-6 expression was reversed by PPARα knockdown. However, suppression by fenofibrate was not reversed by PPARα knockdown but by Sirtuin 1 (SIRT1) knockdown. In conclusion, pemafibrate and fenofibrate similarly suppresses microglial activation but through distinct PPARα and SIRT1-dependet pathways.
巻・号 524(2)
ページ 385-391
公開日 2020-4-2
DOI 10.1016/j.bbrc.2020.01.118
PII S0006-291X(20)30195-9
PMID 32005522
MeSH Animals Anti-Inflammatory Agents / pharmacology* Benzoxazoles / pharmacology* Butyrates / pharmacology* Cell Line Inflammation / drug therapy Inflammation / metabolism Male Mice Mice, Inbred C57BL Microglia / drug effects* Microglia / metabolism PPAR alpha / metabolism* Signal Transduction / drug effects* Sirtuin 1 / metabolism*
IF 2.985
引用数 0
リソース情報
ヒト・動物細胞 MG6(RCB2403)